Inhibition of amyloid beta fibril formation by monomeric human transthyretin-Reference-Cited by-同舟云学术

Inhibition of amyloid beta fibril formation by monomeric human transthyretin

Published:2018-03-14 Issue:7 Volume:27 Page:1252-1261
ISSN:0961-8368
Container-title:Protein Science
language:en
Short-container-title:Protein Science

Author:

Garai Kanchan¹²,Posey Ammon E.¹,Li Xinyi³,Buxbaum Joel N.³,Pappu Rohit V.¹

Affiliation:

1. Department of Biomedical Engineering and Center for Biological Systems Engineering; Washington University in St. Louis, One Brookings Drive, Campus Box 1097; St. Louis Missouri 63130

2. TIFR Centre for Interdisciplinary Sciences, 36/P Gopanpally Village, Serilingampally; Hyderabad 500019 India

3. Department of Molecular and Experimental Medicine; The Scripps Research Institute, 10550 North Torey Pines Road; La Jolla California 92037

Funder

National Institutes of Health

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pro.3396/fullpdf

Reference56 articles.

1. The amyloid state and its association with protein misfolding diseases;Knowles;Nat Rev Mol Cell Biol,2014

2. 2015 Alzheimer's disease facts and figures;Knowles;Alzheimer's Dement,2015

3. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein;Glenner;Biochem Biophys Res Commun,1984

4. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease;McCutchen;Biochemistry,1995

5. Inhibiting transthyretin conformational changes that lead to amyloid fibril formation;Peterson;Proc Natl Acad Sci USA,1998

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease;Molecular Neurobiology;2024-08-27

2. Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases;Molecular Neurodegeneration;2024-02-20

3. New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer’s Disease;Pharmaceutics;2023-09-22

4. Gestational Age-Dependent Regulation of Transthyretin in Mice during Pregnancy;Biology;2023-07-26

5. Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy;International Journal of Molecular Sciences;2022-12-18